Sinclair IS Pharma Share Price (SPH)

0.00 0.00 (0.00%) delayed: 1:22AM GMT
Bid price 0.00 Open price 0.00
Ask price 0.00 Prev close 34.13
High price 0.00 Spread 0.00%
Low price 0.00 Volume 0

Register now for FREE live Sinclair IS Pharma share prices, Sinclair IS Pharma stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Sinclair IS Pharma Level 2 Data, indepth research tools and investor commentary for Sinclair IS Pharma (SPH) and other London Stock Exchange equities.

Sinclair IS Pharma Share Price Chart

Advanced Charts >>

Register now for FREE Sinclair IS Pharma share price charts

Sinclair IS Pharma Share Price Information

Name Sinclair IS Pharma Epic SPH
Sector Pharmaceuticals & Biotechnology ISIN GB0033856740
Activites Sinclair IS Pharma plc (formerly Sinclair Pharma plc) is a speciality pharma company providing solutions to treat dermatological diseases through advanced surface technology and innovative delivery systems. Index n/a

Sinclair IS Pharma Key Numbers

Latest Share Price (p) 0.00 Net Gearing (%) 58.58
Market Capitalisation (£m) 175.77 Gross Gearing (%) 63.01
Shares in issue (m) 502.20 Debt Ratio 55.77
P/E Ratio -23.33 Debt-to-Equity Ratio 0.74
Total dividends per share (p) 0.00 Assets / Equity Ratio 2.70
Dividend Yield (%) 0.00 Price to book value 1.66
Dividend cover (x) 0.00 ROCE (%) -3.41
Earning per share (p) -1.50 EPS Growth (%) -25.00
52 week high / low 40.75 / 26.00 DPS Growth (%) n/a

Sinclair IS Pharma Director Deals

Dec.Date Type Director Pos No. of Shares
05/10/2016 BUY Jeff Thompson NED 150,000
31/05/2016 BUY Jean-Charles Tschudin NED 3,023
31/05/2016 BUY Jean-Charles Tschudin NED 97,000
23/05/2016 BUY Jean-Charles Tschudin NED 250,000
20/05/2016 BUY Christopher Spooner CEO 150,000

More Sinclair IS Pharma Director Deals >>

Sinclair IS Pharma Company News

09:27 17/01/2017

Hardman Research: Demanding targets exceeded

RNS Number : 3509U Sinclair Pharma PLC 17 January 2017   Hardman Research: Demanding targets exceeded Demanding targets exceeded - Sinclair is a pure-play aesthetics company with a concentrated and highly competitive portfolio of differentiated injectable aesthetics...

07:35 17/01/2017

Sinclair Pharma pleased with FY 2016 performance

Sinclair Pharma is pleased with its 2016 performance, a year when it made excellent progress in its strategy to build a leading global pure-play aesthetics company, says CEO Chris Spooner. "Following the radical re-shaping of the business we are now in a position to deliver significant...

07:12 17/01/2017

FLASH: Sinclair Pharma pleased with FY 2016 performance

Story provided by StockMarketWire.com

More Sinclair IS Pharma Company News >>

Register now for FREE Sinclair IS Pharma company news

Sinclair IS Pharma Share Price Discussions

more than 1 year ago

Bargain shares - but only for Directors! (SPH)

However, you read it, the News today that Dir have been given shares at 1p when the Market mid is 28p looks like something out of the book "They never told such a story, you dreamt it" So just what performance does such largess reward, I wonder? Ah yes, the sp has increased 10-fold, ah so....

more than 1 year ago

Take over bid rejected (SPH)

News article which appears to have gone unnoticed. From "THIS IS MONEY" website Ubiquitious Warburg Pincus has completed more initial public offerings (IPOs) than any other private equity firm. It is currently putting its considerable weight behind a proposed $1.5bn IPO of Bausch & Lomb,...

more than 1 year ago

Trading update due July (SPH)

Year end 30th June and a trading update out early July. A couple of Funds have been topping up in recent weeks. 62.5% of shares now with investment funds plus another 3.42% with directors.

Register now for FREE Sinclair IS Pharma share price discussions